BioPharma workflow solutions

Significance of topic

Biopharmaceutical products demand precise analytical workflows to ensure product identity, purity and potency. Robust, reproducible chromatographic and mass spectrometric methods are essential for characterizing biotherapeutics, lipids and nucleic acids across research, QA/QC and manufacturing environments.

Objectives and overview

This whitepaper presents four end-to-end workflows from Thermo Fisher Scientific for key biopharma analyses:

• Charge variant profiling of monoclonal antibodies
• High-throughput mRNA sequence mapping
• Lipidomic profiling in complex samples
• Rapid monoclonal antibody titer determination

Each workflow combines optimized sample preparation, chromatography columns, buffers and consumables to maximize resolution, throughput and data confidence.

Methodology and instrumentation

The workflows integrate:

• Ion exchange chromatography with linear pH gradients for resolving antibody charge variants
• Partial RNase digests (T1, A) coupled to reversed-phase LC and high-resolution MS for mRNA mapping
• Reversed-phase C30 UHPLC separation for high-resolution lipid isomer analysis
• Protein A affinity LC for fast, automated mAb titer assays

Core instrumentation:

• Vanquish Flex UHPLC system with diode array detector (DAD)
• DNAPac RP, Accucore C30, ProPac Elite WCX, MAbPac Protein A columns
• SMART Digest RNase kits, CX-1 pH gradient buffers
• Crome-compatible SureSTART vials and caps

Main results and discussion

Charge variant workflow achieved baseline separation of IgG1 variants in under 20 min using ProPac Elite WCX columns and a 20–70% pH gradient (pH range 5.6–10.2).
mRNA mapping workflow delivered comprehensive sequence coverage of long RNA within 40 min, leveraging automated T1 digestion and DNAPac RP separation.
Lipidomics workflow resolved complex lipid mixtures from human plasma in 32 min on Accucore C30 columns, highlighting shape-based isomer selectivity.
Protein A workflow demonstrated >2000 consistent rabbit IgG injections at 2 mL/min with minimal carryover, achieving rapid titer screening.

Benefits and practical applications

• Streamlined method development with ready-to-use buffers and kits
• High throughput and automation compatibility for QA/QC labs
• Reduced method transfer time across R&D and bioprocess
• Enhanced resolution and reproducibility for regulatory compliance

Future trends and possibilities

Emerging directions include integration of multi-omic workflows, AI-driven chromatographic optimization, novel stationary phases for single-cell biopharmaceutical analysis and further miniaturization of high-resolution assays.

Conclusion

Thermo Fisher’s comprehensive Biopharma workflows—combining advanced UHPLC systems, specialized columns, tailored reagents and consumables—enable reliable, high-throughput characterization of proteins, lipids and nucleic acids. Adoption of these standardized solutions accelerates R&D, simplifies QA/QC transfer and ensures consistent, reproducible results across biopharmaceutical applications.

References

• Thermo Scientific. Application Note: pH gradient analysis of IgG1 therapeutic monoclonal antibodies using ProPac Elite WCX column (5 µm).
• Thermo Scientific. Article: Characterization and sequence mapping of large RNA and mRNA therapeutics using mass spectrometry.
• Thermo Scientific. Article: Rational selection of reverse phase columns for high throughput LC-MS lipidomics.
• Thermo Scientific. Product Manual: MAbPac Protein A column.